Viewing Study NCT00268359


Ignite Creation Date: 2025-12-24 @ 2:51 PM
Ignite Modification Date: 2026-01-02 @ 1:18 PM
Study NCT ID: NCT00268359
Status: COMPLETED
Last Update Posted: 2014-07-21
First Post: 2005-12-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bevacizumab and Irinotecan in Treating Patients With Recurrent or Refractory Gliomas
Sponsor: Duke University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module